Guggenheim Capital’s CATALENT, INC. CTLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-21,416
| Closed | -$1.3M | – | 1943 |
|
|
2024
Q3 | $1.3M | Sell |
21,416
-802
| -4% | -$47.5K | 0.01% | 984 |
|
|
2024
Q2 | $1.25M | Buy |
22,218
+3,276
| +17% | +$183K | 0.01% | 1006 |
|
|
2024
Q1 | $1.07M | Buy |
18,942
+3,915
| +26% | +$212K | 0.01% | 1160 |
|
|
2023
Q4 | $675K | Buy |
15,027
+1,985
| +15% | +$80.3K | 0.01% | 1329 |
|
|
2023
Q3 | $594K | Sell |
13,042
-2,283
| -15% | -$107K | 0.01% | 1338 |
|
|
2023
Q2 | $664K | Sell |
15,325
-874
| -5% | -$38.4K | 0.01% | 1338 |
|
|
2023
Q1 | $1.06M | Sell |
16,199
-5,432
| -25% | -$336K | 0.01% | 1152 |
|
|
2022
Q4 | $974K | Buy |
21,631
+191
| +0.9% | +$10.4K | 0.01% | 1169 |
|
|
2022
Q3 | $1.55M | Buy |
21,440
+213
| +1% | +$21.2K | 0.01% | 945 |
|
|
2022
Q2 | $2.28M | Sell |
21,227
-10,109
| -32% | -$1.03M | 0.02% | 843 |
|
|
2022
Q1 | $3.48M | Buy |
31,336
+1,948
| +7% | +$203K | 0.02% | 800 |
|
|
2021
Q4 | $3.76M | Sell |
29,388
-38,030
| -56% | -$4.89M | 0.02% | 795 |
|
|
2021
Q3 | $8.97M | Buy |
67,418
+11,853
| +21% | +$1.48M | 0.05% | 427 |
|
|
2021
Q2 | $6.01M | Buy |
55,565
+23,700
| +74% | +$2.54M | 0.04% | 607 |
|
|
2021
Q1 | $3.35M | Sell |
31,865
-6,519
| -17% | -$727K | 0.02% | 793 |
|
|
2020
Q4 | $3.99M | Buy |
38,384
+13,606
| +55% | +$1.32M | 0.03% | 686 |
|
|
2020
Q3 | $2.12M | Buy |
24,778
+2,988
| +14% | +$253K | 0.02% | 863 |
|
|
2020
Q2 | $1.6M | Buy |
21,790
+1,479
| +7% | +$100K | 0.01% | 976 |
|
|
2020
Q1 | $1.05M | Sell |
20,311
-1,678
| -8% | -$91.6K | 0.01% | 1060 |
|
|
2019
Q4 | $1.24M | Buy |
21,989
+3,464
| +19% | +$177K | 0.01% | 1255 |
|
|
2019
Q3 | $883K | Buy |
18,525
+197
| +1% | +$10.6K | 0.01% | 1381 |
|
|
2019
Q2 | $993K | Buy |
18,328
+3,056
| +20% | +$140K | 0.01% | 1360 |
|
|
2019
Q1 | $620K | Sell |
15,272
-13,005
| -46% | -$508K | 0.01% | 1583 |
|
|
2018
Q4 | $882K | Sell |
28,277
-9,915
| -26% | -$382K | 0.01% | 1433 |
|
|
2018
Q3 | $1.74M | Sell |
38,192
-16,320
| -30% | -$689K | 0.01% | 1317 |
|
|
2018
Q2 | $2.28M | Sell |
54,512
-224,406
| -80% | -$9.07M | 0.02% | 1173 |
|
|
2018
Q1 | $11.4M | Sell |
278,918
-9,870
| -3% | -$420K | 0.03% | 631 |
|
|
2017
Q4 | $11.9M | Buy |
288,788
+226,122
| +361% | +$9.2M | 0.03% | 637 |
|
|
2017
Q3 | $2.5M | Buy |
62,666
+48,404
| +339% | +$1.79M | 0.01% | 1502 |
|
|
2017
Q2 | $501K | Sell |
14,262
-2,046
| -13% | -$67.3K | ﹤0.01% | 2399 |
|
|
2017
Q1 | $463K | Buy |
16,308
+818
| +5% | +$22.9K | ﹤0.01% | 2406 |
|
|
2016
Q4 | $417K | Sell |
15,490
-8,500
| -35% | -$211K | ﹤0.01% | 2478 |
|
|
2016
Q3 | $620K | Buy |
23,990
+1,354
| +6% | +$33.7K | ﹤0.01% | 2301 |
|
|
2016
Q2 | $520K | Sell |
22,636
-97
| -0.4% | -$2.56K | ﹤0.01% | 2364 |
|
|
2016
Q1 | $606K | Buy |
22,733
+3,230
| +17% | +$78.7K | ﹤0.01% | 2297 |
|
|
2015
Q4 | $488K | Sell |
19,503
-271,398
| -93% | -$7.16M | ﹤0.01% | 2468 |
|
|
2015
Q3 | $7.07M | Buy |
+290,901
| New | +$8.83M | 0.02% | 898 |
|
|
2015
Q1 | – | Sell |
-23,419
| Closed | -$653K | – | 3087 |
|
|
2014
Q4 | $653K | Buy |
+23,419
| New | +$616K | ﹤0.01% | 2415 |
|
Other funds holding CTLT
RAM
IA
EBA
HNB
Guggenheim Capital's CTLT Position: Q4 2024 in Review
Guggenheim Capital sold out of CATALENT, INC. (CTLT) in Q4 2024, closing a stake of 21,416 shares — an estimated $1.3M sold.
Guggenheim Capital first reported a position in CTLT in Q4 2014 and held it in 38 quarters. The position peaked at $11.9M in Q4 2017. 6 funds tracked by Wall St. Rank hold CTLT as of Q4 2024.
- Guggenheim Capital reported no remaining CATALENT, INC. position as of Q4 2024 after selling out during the quarter.
- Guggenheim Capital sold 21,416 CATALENT, INC. shares in Q4 2024, an estimated $1.3M.
- Guggenheim Capital first reported a position in CATALENT, INC. in Q4 2014 and held it in 38 quarters.
- Guggenheim Capital's CATALENT, INC. position peaked at $11.9M in Q4 2017.
- 6 funds tracked by Wall St. Rank held CATALENT, INC. as of Q4 2024.
Based on Guggenheim Capital's 13F filing for Q4 2024, filed 13 Feb 2025.